among the compounds tested , 4'-epi-tetrahydropyranyl-adriamycin appeared to be the least powerful effector , requiring a significantly higher concentration for 50 % inhibition of oxidation than doxorubicin and the other analogues examined .
C0014582
4
C0013089
doxorubicin